Signal transducer and activator of transcription 1 decoy oligodeoxynucleotide suppression of contact hypersensitivity

Journal of Allergy and Clinical Immunology

Volumn 121, Issue 1, 2008, Pages

  Wagner, Andreas H ^a   Wittjen, Inka ^a   Stojanovic, Tomislav ^b   Middel, Peter ^b   Meingassner, Josef G ^c   Hecker, Markus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c Novartis Institutes for Biomedical Research   (Austria)

Author keywords

allergic contact dermatitis; Contact hypersensitivity; decoy oligodeoxynucleotide; gene expression; signal transducer and activator of transcription 1

Indexed keywords

CD40 LIGAND; GAMMA INTERFERON; HAPTEN; INTERLEUKIN 12; INTERLEUKIN 1BETA; OLIGODEOXYNUCLEOTIDE; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE RELEASE; DERMIS; EAR; EDEMA; ERYTHEMA; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 38149058812     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.09.015     Document Type: Article

References (38)

1. Ishizaki K., Yamada A., Yoh K., Nakano T., Shimohata H., Maeda A., et al. Th1 and type 1 cytotoxic T cells dominate responses in T-bet overexpression transgenic mice that develop contact dermatitis. J Immunol 178 (2007) 605-612
2. Saint-Mezard P., Berard F., Dubois B., Kaiserlian D., and Nicolas J.F. The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis. Eur J Dermatol 14 (2004) 131-138
3. Petersen T.K. In vivo pharmacological disease models for psoriasis and atopic dermatitis in drug discovery. Basic Clin Pharmacol Toxicol 99 (2006) 104-115
4. Vana G., and Meingassner J.G. Morphologic and immunohistochemical features of experimentally induced allergic contact dermatitis in Göttingen minipigs. Vet Pathol 37 (2000) 565-580
5. Dilulio N.A., Engeman T., Armstrong D., Tannenbaum C., Hamilton T.A., and Fairchild R.L. GROalpha-mediated recruitment of neutrophils is required for elicitation of contact hypersensitivity. Eur J Immunol 29 (1999) 3485-3495
6. Breuer K., Werfel T., and Kapp A. Allergic manifestations of skin diseases-atopic dermatitis. Chem Immunol Allergy 91 (2006) 76-86
7. Lowes M.A., Bowcock A.M., and Krueger J.G. Pathogenesis and therapy of psoriasis. Nature 445 (2007) 866-873
8. Hartmann B., Staedtler F., Hartmann N., Meingassner J., and Firat H. Gene expression profiling of skin and draining lymph nodes of rats affected with cutaneous contact hypersensitivity. Inflamm Res 55 (2006) 322-334
9. Roumestan C., Henriquet C., Bousquet J., and Mathieu M. Fluticasone propionate and mometasone furoate have equivalent transcriptional potencies. Clin Exp Allergy 33 (2003) 895-901
10. Levin C., and Maibach H.I. An overview of the efficacy of topical corticosteroids in experimental human nickel contact dermatitis. Contact Dermatitis 43 (2000) 317-321
11. Crameri R., and Rhyner C. Novel vaccines and adjuvants for allergen-specific immunotherapy. Curr Opin Immunol 18 (2006) 761-768
12. Dzau V.J. Transcription factor decoy. Circ Res 90 (2002) 1234-1236
13. Quarcoo D., Weixler S., Groneberg D., Joachim R., Ahrens B., Wagner A.H., et al. Inhibition of signal transducer and activator of transcription 1 attenuates allergen-induced airway inflammation and hyperreactivity. J Allergy Clin Immunol 114 (2004) 288-295
14. Hückel M., Schurigt U., Wagner A.H., Stöckigt R., Petrow P.K., Thoss K., et al. Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1). Arthritis Res Ther 8 (2005) R17
15. Hölschermann H., Stadlbauer T.H., Wagner A.H., Fingerhuth H., Muth H., Rong S., et al. STAT-1 and AP-1 decoy oligonucleotide therapy delays acute rejection and prolongs cardiac allograft survival. Cardiovasc Res 71 (2006) 527-536
16. Wagner A.H., Gebauer M., Pollok-Kopp B., and Hecker M. Cytokine-inducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1. Blood 99 (2002) 520-525
17. Lauth M., Wagner A.H., Cattaruzza M., Orzechowski H.D., Paul M., and Hecker M. Transcriptional control of deformation-induced preproendothelin-1 gene expression in endothelial cells. J Mol Med 78 (2000) 441-450
18. Frosch P.J., and Kligman A.M. The soap chamber test. A new method for assessing the irritancy of soaps. J Am Acad Dermatol 1 (1979) 35-41
19. Meingassner J.G., Grassberger M., Fahrgruber H., Moore H.D., Schuurman H., and Stütz A. A potential new anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology. Br J Dermatol 137 (1997) 568-576
20. Dearman R.J., and Kimber I. Role of CD4(+) T helper 2-type cells in cutaneous inflammatory responses induced by fluorescein isothiocyanate. Immunology 101 (2000) 442-451
21. Takeshita K., Yamasaki T., Akira S., Gantner F., and Bacon K.B. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse. Int Immunol 16 (2004) 685-695
22. Fiset P.O., Leung D.Y., and Hamid Q. Immunopathology of atopic dermatitis. J Allergy Clin Immunol 118 (2006) 287-290
23. Nasr I.S. Topical tacrolimus in dermatology. Clin Exp Dermatol 25 (2000) 250-254
24. Alomar A., Berth-Jones J., Bos J.D., Giannetti A., Reitamo S., Ruzicka T., et al. The role of topical calcineurin inhibitors in atopic dermatitis. Br J Dermatol 151 suppl 70 (2004) 3-27
25. Stuetz A., Baumann K., Grassberger M., Wolff K., and Meingassner J.G. Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus. Int Arch Allergy Immunol 141 (2006) 199-212
26. Ohtani M., Kobayashi Y., and Watanabe N. Gene expression in the elicitation phase of guinea pig DTH and CHS reactions. Cytokine 25 (2004) 246-253
27. Tsuji R.F., Kawikova I., Ramabhadran R., Akahira-Azuma M., Taub D., Hugli T.E., et al. Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J Immunol 165 (2000) 1588-1598
28. Natsuaki M., Yano N., Yamaya K., and Kitano Y. Immediate contact hypersensitivity induced by repeated hapten challenge in mice. Contact Dermatitis 43 (2000) 267-272
29. Howie S.E., Aldridge R.D., McVittie E., Forsey R.J., Sands C., and Hunter J.A. Epidermal keratinocyte production of interferon-γ immunoreactive protein and mRNA is an early event in allergic contact dermatitis. J Invest Dermatol 106 (1996) 1218-1223
30. Esche C., de Benedetto A., and Beck L.A. Keratinocytes in atopic dermatitis: inflammatory signals. Curr Allergy Asthma Rep 4 (2004) 276-284
31. Denfeld R.W., Hollenbaugh D., Fehrenbach A., Weiss J.M., von Leoprechting A., Mai B., et al. CD40 is functionally expressed on human keratinocytes. Eur J Immunol 26 (1996) 2329-2334
32. Gaspari A.A., Sempowski G.D., Chess P., Gish J., and Phipps R.P. Human epidermal keratinocytes are induced to secrete interleukin-6 and co-stimulate T lymphocyte proliferation by a CD40-dependent mechanism. Eur J Immunol 26 (1996) 1371-1377
33. Beissert S., Cavazzana I., Mascia F., Meroni P., Pastore S., Tessari G., et al. Mechanisms of immune-mediated skin diseases: an overview. Clin Exp Rheumatol 24 suppl (2006) S1-S6
34. Sumi K., Yokozeki H., Wu M.H., Satoh T., Kaneda Y., Takeda K., et al. In vivo transfection of a cis element "decoy" against signal transducers and activators of transcription 6 (STAT6) binding site ameliorates the response of contact hypersensitivity. Gene Ther 11 (2004) 1763-1771
35. Nakamura H., Aoki M., Tamai K., Oishi M., Ogihara T., Kaneda Y., et al. Prevention and regression of atopic dermatitis by ointment containing NF-κB decoy oligodeoxynucleotides in NC/Nga atopic mouse model. Gene Ther 9 (2002) 1221-1229
36. Dajee M., Muchamuel T., Schryver B., Oo A., Alleman-Sposeto J., De Vry C.G., et al. Blockade of experimental atopic dermatitis via topical NF-κB decoy oligonucleotide. J Invest Dermatol 126 (2006) 1792-1803
37. Isomura I., Tsujimura K., and Morita A. Antigen-specific peripheral tolerance induced by topical application of NF-κB decoy oligodeoxynucleotide. J Invest Dermatol 126 (2006) 97-104
38. Sano S., Chan K.S., Carbajal S., Clifford J., Peavey M., Kiguchi K., et al. STAT3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11 (2005) 43-49